Key result
A higher proportion of non-fatty/non-myxoid components on MRI was found in myxoid liposarcoma patients with poor prognosis compared to those with good prognosis.
Why the study?
Do MRI features of tumor components predict prognosis in patients with myxoid liposarcoma?
Observational (n=20)
Do MRI features of tumor components predict prognosis in patients with myxoid liposarcoma?
MRI features, specifically the proportion of non-fatty/non-myxoid components, are significantly associated with prognosis in patients with myxoid liposarcoma.
Answers are grounded in this paper and cite their sources.
MRI non-fatty/non-myxoid proportion may aid myxoid liposarcoma prognostication; hypothesis-generating and requires prospective validation before clinical use.
Background Myxoid liposarcoma (MLS) is a subtype of liposarcoma characterized by its myxoid stroma and adipocyte differentiation. MLS is prone to recurrence and metastasis. Magnetic resonance imaging (MRI) plays a crucial role in evaluating tumor characteristics, enabling accurate diagnosis, and predicting patient prognosis. Purpose To analyze the components of MLS by MRI features and assess their correlation with prognosis. Material and Methods A total of 20 patients with MLS who underwent MRI were retrospectively included. Tumor components were analyzed by MRI features, and their prognostic correlation was assessed. Patients were divided into good and poor prognosis groups based on postoperative follow-up. Results The proportions of non-fatty/non-myxoid components in the good and poor prognosis groups were 15.00% (range = 10.00%–20.00%) and 70.00% (range = 52.50%–77.50%), respectively ( P < 0.001). The proportion of myxoid composition also differed significantly between the two groups (75.00%, [range = 65.00%–85.00%] vs. 25.00% [range = 17.50%–42.50%]; P < 0.001). The good prognosis group had a greater mean apparent diffusion coefficient (ADC) value (1.66 ± 0.23 × 10 −3 mm 2 /s) and a lower mean ADC low signal ratio (5.00% [range = 0%–10.00%]) in the non-fatty/non-myxoid areas than the poor group (1.21 ± 0.41 × 10 −3 mm 2 /s; 20.00% [range = 11.00%–39.00%]; P = 0.006 and P = 0.001). The differences in the percentages of patients with a component ratio <25% and >50% in both the non-fatty/non-myxoid and myxoid groups were significant ( P < 0.001 and P = 0.005). Conclusion Imaging features were closely associated with the histological components of MLS. The use of MRI features for assessing MLS components has important implications for prognostic prediction.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2025) conducted an observational in Myxoid liposarcoma (MLS) (n=20). Non-fatty/non-myxoid components on MRI vs. Good prognosis group was evaluated on Proportion of non-fatty/non-myxoid components (p=<0.001). A higher proportion of non-fatty/non-myxoid components on MRI was found in myxoid liposarcoma patients with poor prognosis compared to those with good prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: